全文获取类型
收费全文 | 1881篇 |
免费 | 212篇 |
出版年
2022年 | 19篇 |
2021年 | 21篇 |
2020年 | 10篇 |
2019年 | 20篇 |
2018年 | 27篇 |
2017年 | 20篇 |
2016年 | 36篇 |
2015年 | 59篇 |
2014年 | 68篇 |
2013年 | 67篇 |
2012年 | 84篇 |
2011年 | 112篇 |
2010年 | 73篇 |
2009年 | 60篇 |
2008年 | 81篇 |
2007年 | 110篇 |
2006年 | 87篇 |
2005年 | 85篇 |
2004年 | 82篇 |
2003年 | 75篇 |
2002年 | 90篇 |
2001年 | 71篇 |
2000年 | 64篇 |
1999年 | 59篇 |
1998年 | 24篇 |
1997年 | 26篇 |
1996年 | 23篇 |
1995年 | 18篇 |
1994年 | 19篇 |
1993年 | 14篇 |
1992年 | 31篇 |
1991年 | 22篇 |
1990年 | 26篇 |
1989年 | 23篇 |
1988年 | 30篇 |
1987年 | 27篇 |
1986年 | 20篇 |
1985年 | 28篇 |
1984年 | 18篇 |
1983年 | 18篇 |
1982年 | 15篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 12篇 |
1977年 | 15篇 |
1976年 | 14篇 |
1974年 | 17篇 |
1972年 | 13篇 |
1971年 | 15篇 |
1970年 | 14篇 |
排序方式: 共有2093条查询结果,搜索用时 15 毫秒
941.
Sumanth Polikepahad Wade T. Barranco Paul Porter Bruce Anderson Farrah Kheradmand David B. Corry 《Journal of visualized experiments : JoVE》2010,(38)
Airway hyperreactivity (AHR) measurements and bronchoalveolar lavage (BAL) fluid sampling are essential to experimental asthma models, but repeated procedures to obtain such measurements in the same animal are generally not feasible. Here, we demonstrate protocols for obtaining from mice repeated measurements of AHR and bronchoalveolar lavage fluid samples. Mice were challenged intranasally seven times over 14 days with a potent allergen or sham treated. Prior to the initial challenge, and within 24 hours following each intranasal challenge, the same animals were anesthetized, orally intubated and mechanically ventilated. AHR, assessed by comparing dose response curves of respiratory system resistance (RRS) induced by increasing intravenous doses of acetylcholine (Ach) chloride between sham and allergen-challenged animals, were determined. Afterwards, and via the same intubation, the left lung was lavaged so that differential enumeration of airway cells could be performed. These studies reveal that repeated measurements of AHR and BAL fluid collection are possible from the same animals and that maximal airway hyperresponsiveness and airway eosinophilia are achieved within 7-10 days of initiating allergen challenge. This novel technique significantly reduces the number of mice required for longitudinal experimentation and is applicable to diverse rodent species, disease models and airway physiology instruments. Download video file.(109M, mp4) 相似文献
942.
943.
Vega C Moreno-Carranza B Zamorano M Quintanar-Stéphano A Méndez I Thebault S Martínez de la Escalera G Clapp C 《American journal of physiology. Regulatory, integrative and comparative physiology》2010,299(6):R1701-R1708
Prolactin (PRL) stimulates the secretion of oxytocin (OXT) and arginine AVP as part of the maternal adaptations facilitating parturition and lactation. Both neurohormones are under the regulation of nitric oxide. Here, we investigate whether the activation of neuronal nitric oxide synthase (nNOS) in the hypothalamo-neurohypophyseal system mediates the effect of PRL on OXT and AVP release and whether these effects operate in males. Plasma levels of OXT and AVP were measured in male rats after the intracerebroventricular injection of PRL or after inducing hyperprolactinemia by placing two anterior pituitary glands under the kidney capsule. NOS activity was evaluated in the paraventricular (PVN) and supraoptic (SON) hypothalamic nuclei by NADPH-diaphorase histochemistry and in hypothalamic extracts by the phosphorylation/inactivation of nNOS at Ser(847). Elevated central and systemic PRL correlated with increased NOS activity in the PVN and SON and with higher OXT and AVP circulating levels. Notably, treatment with 7-nitroindazole, a selective inhibitor of nNOS, prevented PRL-induced stimulation of the release of both neurohormones. Also, phosphorylation of nNOS was reduced in hyperprolactinemic rats, and treatment with bromocriptine, an inhibitor of anterior pituitary PRL secretion, suppressed this effect. These findings suggest that PRL enhances nNOS activity in the PVN and SON, thereby contributing to the regulation of OXT and AVP release. This mechanism likely contributes to the regulation of processes beyond those of female reproduction. 相似文献
944.
945.
946.
947.
Padraick J. Dornbush Cynric Cho Elizabeth S. Chang Lu Xu Wade A. Russu Lisa A. Wrischnik Kirkwood M. Land 《Bioorganic & medicinal chemistry letters》2010,20(17):5299-5301
Trichomonas vaginalis, a human-infectious protozoan, can display resistance to treatment by metronidazole. A library of 3,4-dichloroaniline amides based on propanil, an herbicide, has been synthesized and screened to test susceptibility to these analogs. From this preliminary study, the most effective compound 15, inhibits growth of the organism by 66% and 69% on the two strains tested, T1 and G3, respectively. 相似文献
948.
949.
Ami A Shah Elena Schiopu Laura K Hummers Michael Wade Kristine Phillips Cynthia Anderson Robert Wise Francesco Boin James R Seibold Fredrick Wigley Kristan D Rollins 《Arthritis research & therapy》2013,15(2)
Introduction
Treprostinil diethanolamine is an innovative salt form of the prostacyclin analogue, treprostinil sodium, developed as an oral sustained release (SR) osmotic tablet. The availability of a formulation permitting convenient systemic delivery might have applicability to scleroderma vascular complications. We evaluated pharmacokinetics and perfusion in scleroderma patients with digital ischemia following escalating twice-daily doses of treprostinil diethanolamine SR.Methods
Scleroderma patients with digital ulcers were enrolled in this dual-center, open-label, phase I pharmacokinetic study. Drug concentrations and perfusion, quantified by laser Doppler imaging, were measured over 12 hours at the 2 mg and 4 mg (or maximally tolerated) doses. Pharmacokinetic parameters were determined from individual plasma concentration versus time profiles using non-compartmental analysis methods. Digital perfusion and skin temperature were modeled as a function of log-transformed drug concentration and other covariates by performing repeated measures analyses using random effects models.Results
Nineteen scleroderma patients (84% female, 53% limited scleroderma) received treprostinil diethanolamine SR with dose titration up to 4 mg twice daily as tolerated. Peak concentrations (mean maximum plasma concentration (Cmax) = 1,176 and 2,107 pg/mL) occurred approximately 3.6 hours after dose administration, and overall exposure (under the plasma concentration-time curve from time 0 to 12 hours post dose (AUC0-12) = 7,187 and 12,992 hr*pg/mL) was linear between the 2 mg and 4 mg doses. Perfusion and digital skin temperature were positively associated with log-transformed plasma concentration at the 4 mg dose (P = 0.015 and P = 0.013, respectively). The most frequent adverse events were similar to those seen with prostacyclin analogues.Conclusions
Oral treprostinil diethanolamine was effectively absorbed in patients with scleroderma. Drug administration was temporally associated with improved cutaneous perfusion and temperature. Treprostinil diethanolamine may provide a new therapeutic option for Raynaud''s phenomenon and the peripheral vascular disease of scleroderma.Trial Registration
ClinicalTrials.gov . NCT00848939Electronic supplementary material
The online version of this article (doi:10.1186/ar4216) contains supplementary material, which is available to authorized users. 相似文献950.